| Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. | thyroid, |
| Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels. | thyroid, |
| Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1. | thyroid, |
| Assessment of RET/PTC oncogene activation in thyroid nodules utilizing laser microdissection followed by nested RT-PCR. | thyroid, |
| siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. | thyroid, |
| Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors. | thyroid, |
| Effects of silencing the RET/PTC1 oncogene in papillary thyroid carcinoma by siRNA-squalene nanoparticles with and without fusogenic companion GALA-cholesterol. | thyroid, |
| RET/PTC oncogene activation is an early event in thyroid carcinogenesis. | thyroid, |
| The ret/PTC oncogene in papillary thyroid carcinoma. | thyroid, |
| Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. | thyroid, |
| Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. | thyroid, |
| Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. | thyroid, |
| Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. | thyroid, |
| Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene. | thyroid, |
| Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. | thyroid, |
| The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. | thyroid, |
| RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. | thyroid, |
| Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative. | None |
| XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. | None |
| Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. | None |